Somatostatin and somatostatin receptors in retinal diseases [PDF]
Averst, E. (Ellen) ter +7 more
core +2 more sources
Erythropoietin and diabetic macular oedema [PDF]
A Fonollosa, J Garcia-Arumi
openaire +1 more source
Clinical practice guidelines for the treatment and management of diabetic macular oedema: a systematic review. [PDF]
McAllister M +9 more
europepmc +1 more source
Comparison of the clinical effect of intravitreal ranibizumab and intravitreal dexamethasone implants in the treatment of retinal vein occlusion complicated with macular oedema: a meta-analysis. [PDF]
Li Y, Hu L, Zu J.
europepmc +1 more source
First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report. [PDF]
Saad A +20 more
europepmc +1 more source
Phase 1 dose-escalation study of IBI324, a VEGF-A/Ang-2 bispecific antibody, for the treatment of diabetic macular oedema. [PDF]
Wang Z +11 more
europepmc +1 more source
Beyond the First Year of Intravitreal Faricimab for Diabetic Macular Oedema: A Single-Centre Experience. [PDF]
Tsilegeridis-Legeris T, Kenawy N.
europepmc +1 more source
Retinal Organisation and Systemic Vascular Changes Assessed by Adaptive Optics and Doppler Ultrasonography Following Anti-VEGF Therapy in Patients with Diabetic Macular Oedema. [PDF]
Pieczyński J, Berlińska A, Harazny JM.
europepmc +1 more source
Biomarkers of risk of switching to dexamethasone implant for the treatment of diabetic macular oedema in real clinical practice: a multicentric study. [PDF]
Ruiz-Medrano J +12 more
europepmc +1 more source

